ALK molecular phenotype in non-small cell lung cancer: CT radiogenomic characterization.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

To present a radiogenomic computed tomographic (CT) characterization of anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer (NSCLC) (ALK+).

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Radiology

Title: Radiology

Publisher: Radiological Society of North America (RSNA)

ISSN (Electronic): 1527-1315

ISSN (Print): 0033-8419

Publication date (Electronic): Aug 2014

Volume: 272

Issue: 2

Affiliations

[1 ] From the Department of Radiological Sciences, David Geffen School of Medicine at UCLA, 10833 Le Conte Ave, Box 951721, CHS 17-135, Los Angeles, CA 90095-1721 (S.Y., C.M., M.D.K.); Scottsdale Medical Imaging, Scottsdale, Ariz (R.L.K.); Scottsdale Healthcare, Scottsdale, Ariz (R.L.K.); Departments of Vascular Interventional Radiology (R.O.) and Pathology (A.J.I.), Massachusetts General Hospital, Harvard Medical School, Boston, Mass; Department of Radiology, Mayo Clinic, Phoenix, Ariz (M.B.G.); Department of Radiology, Mayo Clinic, Scottsdale, Ariz (M.B.G.); Cancer Treatment Centers of America, Goodyear, Ariz (G.J.W.); Translational Genomics Research Institute, Phoenix, Ariz (G.J.W.); and Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea (D.W.K.).

Article

DOI: 10.1148/radiol.14140789

PubMed ID: 24885982

SO-VID: bf3c3951-733c-4224-a9ba-84b216fc2fcd

History

Data availability:

Comments

Comment on this article

scite_

Cited by 59

See all cited by